Millennium Affiliate Discloses Stake in Terns Pharmaceuticals

TL;DR

**Millennium affiliate just bought Terns Pharma stock, signaling institutional interest.**

AI Summary

Integrated Core Strategies (US) LLC, part of Millennium Management LLC, filed an SC 13G on January 25, 2024, disclosing its ownership of Terns Pharmaceuticals, Inc. common stock as of January 18, 2024. This filing indicates that a significant institutional investor has taken a position in Terns Pharmaceuticals, which could signal confidence in the company's future prospects and potentially attract other investors, influencing the stock price.

Why It Matters

This filing shows a major institutional investor, Integrated Core Strategies (US) LLC, has bought into Terns Pharmaceuticals, which can be seen as a vote of confidence and might attract more investor attention to the stock.

Risk Assessment

Risk Level: low — This filing is a disclosure of ownership and does not inherently present a direct risk, but rather provides transparency on institutional holdings.

Analyst Insight

An investor might view this as a positive signal, suggesting that a sophisticated institutional investor sees value in Terns Pharmaceuticals. It would be wise to research Terns Pharmaceuticals' recent news and financials to understand why Integrated Core Strategies (US) LLC might have taken this position.

Key Players & Entities

• Integrated Core Strategies (US) LLC (company) — reporting person and institutional investor
• Terns Pharmaceuticals, Inc. (company) — subject company whose stock was acquired
• Millennium Management LLC (company) — parent company of the reporting person
• Israel A. Englander (person) — group member associated with Millennium
• Millennium Group Management LLC (company) — group member associated with Millennium
• January 18, 2024 (date) — date of event requiring the filing
• January 25, 2024 (date) — filing date of the SC 13G
• Delaware (company) — place of organization for Integrated Core Strategies (US) LLC

FAQ

Key Financial Figures

• $0.0001 — me of Issuer) COMMON STOCK, PAR VALUE $0.0001 PER SHARE (Title of Class of Securiti

Filing Documents

• TERN_SC13G_2024.htm (SC 13G) — 92KB
• 0001319244-24-000012.txt ( ) — 94KB

If this statement is filed pursuant to Rule 13d-1(b), or 13d-2(b), check whether the person filing is

Item 3. If this statement is filed pursuant to Rule 13d-1(b), or 13d-2(b), check whether the person filing is a: (a) o Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o); (b) o Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c); (c) o Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c); (d) o Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8); (e) o An investment adviser in accordance with 240.13d-1(b)(1)(ii)(E); (f) o An employee benefit plan or endowment fund in accordance with 240.13d-1(b)(1)(ii)(F); CUSIP No. 880881107 SCHEDULE 13G Page 7 of 11 (g) o A parent holding company or control person in accordance with 240.13d-1(b)(1)(ii)(G); (h) o A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) o A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); (j) o Group, in accordance with 240.13d-1(b)(1)(ii)(J).

Ownership

Item 4. Ownership Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. (a) Amount Beneficially Owned: See response to Item 9 on each cover page. (b) Percent of Class: See response to Item 11 on each cover page. (c) Number of shares as to which such person has: (i) Sole power to vote or to direct the vote See response to Item 5 on each cover page. CUSIP No. 880881107 SCHEDULE 13G Page 8 of 11 (ii) Shared power to vote or to direct the vote See response to Item 6 on each cover page. (iii) Sole power to dispose or to direct the disposition of See response to Item 7 on each cover page. (iv) Shared power to dispose or to direct the disposition of See response to Item 8 on each cover page. The securities disclosed herein as potentially beneficially owned by Millennium Management LLC, Millennium Group Management LLC and Mr. Englander are held by entities subject to voting control and investment discretion by Millennium Management LLC and/or other investment managers that may be controlled by Millennium Group Management LLC (the managing member of Millennium Management LLC) and Mr. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). The foregoing should not be construed in and of itself as an admission by Millennium Management LLC, Millennium Group Management LLC or Mr. Englander as to beneficial ownership of the securities held by such entities.

Ownership of Five Percent or Less of a Class

Item 5. Ownership of Five Percent or Less of a Class If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following o .

Ownership of More than Five Percent on Behalf of Another Person

Item 6. Ownership of More than Five Percent on Behalf of Another Person. Not applicable.

Identification and Classification of the Subsidiary Which Acquired

Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company. Not applicable.

Identification and Classification of Members of the Group

Item 8. Identification and Classification of Members of the Group See Exhibit I.

Notice of Dissolution of Group

Item 9. Notice of Dissolution of Group Not applicable.

Certification

Item 10. Certification By signing below each of the undersigned certifies that, to the best of its knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. CUSIP No. 880881107 SCHEDULE 13G Page 9 of 11 Exhibits: Exhibit I: Joint Filing Agreement, dated as of January 24, 2024, by and among Integrated Core Strategies (US) LLC, Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander. CUSIP No. 880881107 SCHEDULE 13G Page 10 of 11 SIGNATURE After reasonable inquiry and to the best of its knowledge and belief, each of the undersigned certifies that the information with respect to it set forth in this statement is true, complete, and correct. Dated: January 24, 2024 INTEGRATED CORE STRATEGIES (US) LLC By: Integrated Holding Group LP, its Managing Member By: Millennium Management LLC, its General Partner By: /s/Gil Raviv Name: Gil Raviv Title: Global General Counsel MILLENNIUM MANAGEMENT LLC By: /s/Gil Raviv Name: Gil Raviv Title: Global General Counsel MILLENNIUM GROUP MANAGEMENT LLC By: /s/Gil Raviv Name: Gil Raviv Title: Global General Counsel /s/ Israel A. Englander Israel A. Englander CUSIP No. 880881107 SCHEDULE 13G Page 11 of 11 EXHIBIT I JOINT FILING AGREEMENT This will confirm the agreement by and among the undersigned that the Schedule 13G filed with the Securities and Exchange Commission on or about the date hereof with respect to the beneficial ownership by the undersigned of the Common Stock, par value $0.0001 per share, of Terns Pharmaceuticals, Inc. will be filed on behalf of each of the persons and entities named below in accordance with Rule 13d-1(k) under the Securities Exchange Act of 1

View Full Filing

View this SC 13G filing on SEC EDGAR